blog

New Partnership with Health Union Shines the Light on the Patient Voice

By BBK Worldwide on Tue, Sep 10, 2019 | 7 min read

BLOG_IMAGE

We recently had the opportunity to sit down with Lauren Lawhon, chief operating officer for Health Union, to discuss our newly formed partnership with the pioneer in online communities and how greater insight into the patient voice can enhance the clinical trial patient experience.

Topics: Patient, Patient Experience, Study Voices, Health Union

With Kindness and Courtesy: RSG® Arrive Driver of the Month

By Elizabeth Gargill on Wed, Aug 14, 2019 | 3 min read

As RSG® Arrive continues to transform the clinical trial patient experience – enhancing access to care, removing barriers to participation, and fostering long-term engagement – we recognize Mike as our driver of the month. He exemplifies the qualities that set RSG® Arrive apart – dedication, commitment to care, and professionalism.

Topics: Patient Travel, Patient Experience

How Precision Medicine is Influencing Clinical Trials

By BBK Worldwide on Tue, Jun 4, 2019 | 1 min read

As originally conceived, personalized medicine referred to the tailoring of medical treatment to the individual characteristics of each patient. The right drug for the right patient at the right timehas since evolved to an approach that takes into account individual differences in people’s genes, environments, and lifestyles. 

Topics: Patient Experience, Pharma15 Live!, Vlog, Precision Medicine, Precision Support

BBK's Privacy Expert Shares His View on the Positive Trend in Patient Trust in Clinical Trials

By BBK Worldwide on Tue, Jun 4, 2019 | 1 min read

A recent survey shared in FiercePharma pointed to an upward trend in general public opinion of the pharmaceutical industry. But there is still work to be done.* 

Rob Laurens, Principal, Human Resources and Quality Assurance, credits much of this momentum to the work of everyone in the clinical R&D sector. 

Topics: Clinical Research, Big Data, Patient Experience, Pharma15 Live!, Vlog, Privacy

Small to Mid-Size Pharmaceutical Companies Are Meeting the Needs of a Shifting Marketplace

By Joan F. Bachenheimer on Tue, Jun 4, 2019 | 2 min read

Last year, smaller companies led in new drug approvals, according to a recent OutsourcingPharma.com article featuring Ken Getz, director of sponsored research at Tufts University. Notably, nearly half of these new drugs were for the treatment of rare diseases, demonstrating a shift within the industry away from a focus on scaling infrastructure.*

Scaling-down-Clinical-research-shifts-its-focus_wrbm_large

CEO and Founding Principal of BBK Worldwide, Joan F. Bachenheimer, responds to the article, explaining that “the precision aspects of clinical trial discovery have remapped the patient experience. The more targeted the investigational therapy, the more individualized the orientation becomes toward patient recruitment and engagement. It’s logical that the search for patients with specific biomarkers begets an orientation centered on individual needs versus a mass orientation."

Topics: Trends, Clinical Research, Rare Disease Research, Patient Experience, Precision Medicine

Going the Extra Mile: RSG® Arrive Driver of the Month

By Elizabeth Gargill on Fri, May 3, 2019 | 2 min read

BBK’s RSG® Arrive patient travel program continues to stand out in an increasingly crowded marketplace of companies offering concierge travel and ride-hailing services. One of the reasons RSG® Arrive is in a class by itself is the dedication, commitment to care, and professionalism of its drivers. They routinely go above and beyond to ensure the comfort and care of their passengers.

Viken-Mardirossian-Square

To recognize the important role that our RSG® Arrive drivers play in enhancing the clinical trial patient experience, we will be celebrating a driver of the month, starting this month with Viken.

Topics: Patient Travel, Patient Experience

Focus 5: Amplifying the Study Voice - Capturing the Sentiment of the Study Community

By BBK Worldwide on Wed, Apr 3, 2019 | 2 min read

When examining the clinical trial experience, there’s nothing more meaningful than hearing directly from those closest to the study – patients, caregivers, physicians, and study sponsors. This year BBK launched its Study Voices initiative. Study Voices is designed to capture the sentiment of the study community at a time when the clinical research industry is growing and evolving. From innovative technology, to protocol design, and everything in between, Study Voices captures the perspectives of those closest to the clinical trial experience, offering insight that can be leveraged for action.

“Focus 5: Amplifying the Study Voice” highlights five members of the study community as they share their perspectives on the clinical trial experience.

Topics: Patient Engagement, Rare Disease, Pediatric Studies, Informed Consent, Patient Experience, Study Voices

Guest Spotlight: Annie Finstein A Message to the Medical Community

By Beth Davis Heppenstall on Tue, Feb 5, 2019 | 5 min read

Rounding out our Study Voices panel for BBK's keynote “Do Engagement Tools Live Up to Their Hype?” is panelist, Annie Finstein. She is looking forward to sharing her experience as a patient and participant in a clinical research study on February 19 at the SCOPE conference. 

Annie was diagnosed with Crohn's disease in 2000 at nine years old. After trying all available medications approved for pediatric patients at that time, she participated in a pediatric study at Massachusetts General Hospital in Boston. Now in her late 20s, she enjoys spending time at the beach, hiking, cooking and gardening at her home in Boston. Annie is committed to making a difference and connects with other patients impacted by Crohn’s disease by running half marathons with Team Challenge, the Crohn's & Colitis Foundation’s endurance training and fundraising program.Annie_Finstein

What was most rewarding to you as a participant in a clinical research study?

It was most rewarding to know that I was helping advance the treatment of Crohn’s disease for pediatric patients, and that my participation might not only help me but also other kids suffering from inflammatory bowel disease (IBD).

Topics: Patient Retention, Patient Recruitment, Patient Engagement, Patient Centricity, Patient Advocacy, Conferences, Clinical Trials, Patient, Patient Experience

Guest Spotlight: Dr. Linda Glaser How Do You Define Patient Engagement?

By Beth Davis Heppenstall on Fri, Feb 1, 2019 | 3 min read

We are excited to introduce one of our dynamic keynote panelists, Linda A. Glaser, MD, PhD of Coastal Biomedical Research, Inc. in Santa Monica, CA.

Linda will be sharing her site voice and insights at BBK’s Pharma15 Live! debate series at the 10th Annual SCOPE Summit on Feb 19.

While pursuing a successful career in private practice, Linda’s passion for research lead her to establish Coastal Biomedical Research, Inc. in Santa Monica. The practice specializes in clinical trials across many therapies, from diabetes to hypertension to pain management. As Medical Director, she understands the patient experience and medical site needs. As a business owner, she also understands the importance of adaptability, efficiencies and overcoming operational challenges.

What is most rewarding to you as you consider your contribution to clinical trial research?

The ability to help advance science and treat disease.

How do you define patient engagement? What does that term mean to you?

Topics: Patient Retention, Patient Recruitment, Physician Engagement, Conferences, Site Engagement, Clinical Research, Patient Experience, Pharma15 Live!

Guest Spotlight: Gerald Dryden Site Feasibility and Protocol Design

By Beth Davis Heppenstall on Fri, Feb 1, 2019 | 5 min read

BBK’s signature Pharma15 Live! web series is coming to the 10th Annual SCOPE Summit for Clinical Ops Executives. On February 19, Bonnie A. Brescia, BBK’s founding principal, will moderate a panel during the conference’s plenary keynote program on the topic of “Do Engagement Tools Live Up to Their Hype?” 

We are pleased to introduce one of our panelists, Gerald Wayne Dryden, Jr., MD, PhD, MSPH, MSc of University of Louisville, Kentucky.

Dr. Gerald Dryden

Dr. Gerald “Tad” Dryden is Professor of Medicine and Director of the Inflammatory Bowel Disease Program in the Division of Gastroenterology at the University of Louisville in Louisville, KY.  He earned his MD at the University of Kentucky College of Medicine in Lexington, KY, and completed his internal medicine internship and residency at the Naval Medical Center in Portsmouth, VA. He then completed his gastroenterology fellowship at the Naval Medical Center in San Diego, CA.  During his tenure at the University of Louisville, he earned a Master of Science in Public Health, a Master of Science in Microbiology and Immunology, and a PhD in Microbiology and Immunology. Dr. Dryden’s research interests include developing new therapies from botanical sources and new medical devices to improve endoscopic care.

What is most rewarding to you as you consider your contribution to clinical trial research?

It is very rewarding when I am involved with a drug from the ground up -- seeing research patients benefit from the drug, then eventually being able to prescribe it to my clinic patients.

Topics: Patient Retention, Patient Recruitment, Physician Referrals, Patient Engagement, Site Support, Patient, Patient Experience, Pharma15 Live!

 
Subscribe To Our Blog